Inositol phosphoglycan P-type in infants of preeclamptic mothers

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 2, 2012, Pages 193-195

  Scioscia, Marco ^a,b   Robillard, Pierre Yves ^c   Hall, David R ^d   Rademacher, Laurens H ^f   Williams, Philip J ^e   Rademacher, Thomas W ^e,f  

^a GENERAL HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c Centre Hospitalier Regional Neonatologie   (France)

^d STELLENBOSCH UNIVERSITY   (South Africa)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Inositol; Preeclampsia; Pregnancy

Indexed keywords

INOSITOL DERIVATIVE; INOSITOL PHOSPHOGLYCAN P TYPE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CARBOHYDRATE SYNTHESIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FETUS; HUMAN; MATERNAL HYPERTENSION; NEWBORN; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; SENSITIVITY AND SPECIFICITY; UPREGULATION; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; INOSITOL PHOSPHATES; POLYSACCHARIDES; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES;

EID: 84855674834     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.557789     Document Type: Article

References (8)

1. Williams PJ, Gumaa K, Scioscia M, Redman CW, Rademacher TW. Inositol phosphoglycan P-type in preeclampsia: a novel marker? Hypertension 2007; 49: 84-89. (Pubitemid 46360345)
2. Paine MA, Scioscia M, Williams PJ, Gumaa K, Rodeck CH, Rademacher TW. Urinary inositol phosphoglycan P-type as a marker for prediction of preeclampsia and novel implications for the pathophysiology of this disorder. Hypertens Pregnancy 2010; 29: 375-384.
3. Scioscia M, Gumaa K, Rademacher TW. The link between insulin resistance and preeclampsia: new perspectives. J Reprod Immunol 2009; 82: 100-105.
4. Scioscia M, Greco P, Selvaggi LE, Rademacher TW. Is there a link between insulin resistance and inflammatory activation in preeclampsia? Med Hypotheses 2009; 73: 813-817.
5. Scioscia M, Gumaa K, Kunjara S, Paine MA, Selvaggi LE, Rodeck CH, Rademacher TW. Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and-2. J Clin Endocrinol Metab 2006; 91: 709-717. (Pubitemid 43236947)
6. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
7. Scioscia M, Vimercati A, Selvaggi LE, Rodeck CH, Rademacher TW. Inositol phosphoglycan putative insulin mediator in human amniotic fluid. J Matern Fetal Neonatal Med 2006; 19: 9-12.
8. Robillard PY, Dekker G, Chaouat G, Hulsey TC. Etiology of preeclampsia: maternal vascular predisposition and couple disease-mutual exclusion or complementarity? J Reprod Immunol 2007; 76: 1-7. (Pubitemid 350110356)